These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 27448402)

  • 1. Blood Pressure Targets in CKD: Lessons Learned from SPRINT and Previous Observational Studies.
    Gosmanova EO; Kovesdy CP
    Curr Cardiol Rep; 2016 Sep; 18(9):88. PubMed ID: 27448402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension in chronic kidney disease after the Systolic Blood Pressure Intervention Trial: targets, treatment and current uncertainties.
    Kovesdy CP
    Nephrol Dial Transplant; 2017 Apr; 32(suppl_2):ii219-ii223. PubMed ID: 28201651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Hypertension: Which Goal for Which Patient?
    Jarraya F
    Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?
    Bhatt H; Ghazi L; Calhoun D; Oparil S
    Curr Cardiol Rep; 2016 Oct; 18(10):98. PubMed ID: 27566331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis.
    Malhotra R; Nguyen HA; Benavente O; Mete M; Howard BV; Mant J; Odden MC; Peralta CA; Cheung AK; Nadkarni GN; Coleman RL; Holman RR; Zanchetti A; Peters R; Beckett N; Staessen JA; Ix JH
    JAMA Intern Med; 2017 Oct; 177(10):1498-1505. PubMed ID: 28873137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In the Wake of Systolic Blood Pressure Intervention Trial: New Targets for Improving Hypertension Management in Chronic Kidney Disease?
    Tyson CC; Coffman TM
    Nephron; 2017; 135(4):287-290. PubMed ID: 28161697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood Pressure Parameters and their Associations with Death in Patients with Chronic Kidney Disease.
    Qureshi S; Lorch R; Navaneethan SD
    Curr Hypertens Rep; 2017 Oct; 19(11):92. PubMed ID: 29046987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Are Optimal Blood Pressure Targets for Patients with Hypertension and Chronic Kidney Disease?
    Modi GK; Agarwal R
    Curr Cardiol Rep; 2015 Nov; 17(11):101. PubMed ID: 26374454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPRINT and the Kidney: What Have We Learned?
    Wells R; Rahman M
    Curr Hypertens Rep; 2018 Sep; 20(11):95. PubMed ID: 30218213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between blood pressure and kidney diseases in large randomized controlled trials: secondary analyses using SPRINT and ACCORD-BP trials.
    Wang L; Pezeshkian K; Rayamajhi S; Herzallah K; Al-Abcha A; Olomu A; Kelly-Blake K; Yu E; Wang DH
    J Hum Hypertens; 2021 Oct; 35(10):859-869. PubMed ID: 33093616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of Blood Pressure Measurement Technique for Implementation of Systolic Blood Pressure Intervention Trial (SPRINT).
    Agarwal R
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure control in patients with chronic kidney disease.
    Lee JY; Han SH
    Korean J Intern Med; 2021 Jul; 36(4):780-794. PubMed ID: 34153181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure targets and kidney and cardiovascular disease: same data but discordant guidelines.
    Roehm B; Weiner DE
    Curr Opin Nephrol Hypertens; 2019 May; 28(3):245-250. PubMed ID: 30762614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of SPRINT on the future treatment of hypertension: a mini review.
    Chrysant SG
    Drugs Today (Barc); 2016 Mar; 52(3):193-8. PubMed ID: 27186593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Limitations of blood pressure target in non-dialysis chronic kidney disease: a question of method?].
    Borrelli S; De Nicola L; Minutolo R; Sagliocca A; Garofalo C; Liberti ME; Pacilio M; Iorio V; Michini C; Pirro L; Conte G
    G Ital Nefrol; 2012; 29(4):418-24. PubMed ID: 22843154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the KDIGO Systolic Blood Pressure Target <120 mm Hg for Chronic Kidney Disease Appropriate in Routine Clinical Practice?
    Dasgupta I; Zoccali C
    Hypertension; 2022 Jan; 79(1):4-11. PubMed ID: 34784720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalizability of SPRINT-CKD cohort to CKD patients referred to renal clinics.
    Minutolo R; De Nicola L; Gallo C; Chiodini P; Provenzano M; Conte G; Garofalo C; Borrelli S;
    J Nephrol; 2019 Jun; 32(3):429-435. PubMed ID: 30673974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure management in hypertensive people with non-dialysis chronic kidney disease in Queensland, Australia.
    Zhang J; Healy HG; Venuthurupalli SK; Tan KS; Wang Z; Cameron A; Hoy WE
    BMC Nephrol; 2019 Sep; 20(1):348. PubMed ID: 31484506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which Target Blood Pressure in Year 2018? Evidence from Recent Clinical Trials.
    Heimark S; Mariampillai JE; Narkiewicz K; Nilsson PM; Kjeldsen SE
    High Blood Press Cardiovasc Prev; 2018 Jun; 25(2):151-158. PubMed ID: 29663195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive systolic blood pressure control in older subjects: benefits and risks.
    Chrysant SG
    Postgrad Med; 2018 Mar; 130(2):159-165. PubMed ID: 29375010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.